Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Adverse Events and Safety of SARS-Cov2 Vaccines: What’s New and What’s Next

Corey, K.B., Koo, G. and Phillips, E.J. (2022) Adverse Events and Safety of SARS-Cov2 Vaccines: What’s New and What’s Next. The Journal of Allergy and Clinical Immunology: In Practice .

PDF - Authors' Version
Embargoed until May 2023.

Link to Published Version:
*Subscription may be required


Just over one year following rollout of the first vaccines for coronavirus disease 2019 (COVID-19), 572 million doses have been administered in the United States. Comparatively to the number of vaccines administered, adverse effects such as anaphylaxis have been rare, and seemingly, the more serious the effect, the rarer the occurrence. Despite these adverse effects, there are few, if any, true contraindications to COVID-19 vaccination and most individuals recover without further sequelae. This review provides guidance for the allergist/immunologist regarding appropriate next steps based on patient’s known allergy history or adverse reaction after receipt of COVID-19 vaccine in order to assist in safe global immunization.

Item Type: Journal Article
Murdoch Affiliation(s): Institute for Immunology and Infectious Diseases
Publisher: Elsevier
Copyright: © 2022 Elsevier Ltd and Techna Group S.r.l.
Item Control Page Item Control Page